Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

© 2026 Go Backs. All rights reserved.

Medium RiskFDA Drug
Medications & Supplements/Prescription Drugs

Tirosint-Sol (levothyroxine sodium) Recalled for Subpotency

Agency Publication Date: February 21, 2023
Share:
Sign in to monitor this recall

Summary

IBSA Pharma Inc. has voluntarily recalled multiple lots of Tirosint-Sol (levothyroxine sodium) Oral Solution because the medication may be subpotent. This means the solution might not contain the full amount of active medicine required to treat thyroid conditions effectively. The recall affects 15 different dosage strengths, each packaged in boxes containing six pouches of five ampules. No injuries or adverse events related to this issue have been reported to date.

Risk

Subpotent medication can lead to inadequate treatment of hypothyroidism (underactive thyroid), potentially resulting in symptoms such as fatigue, weight gain, and cold intolerance. There is a risk that patients may not receive their intended dose, leading to poor control of their thyroid levels.

What You Should Do

  1. This recall involves Tirosint-Sol (levothyroxine sodium) Oral Solution in various dosage strengths ranging from 13 mcg/mL to 200 mcg/mL, sold in boxes containing 30 total ampules (6 pouches of 5 ampules).
  2. Identify if your medication is affected by checking the National Drug Code (NDC) and lot number printed on the product packaging or carton. See the Affected Products section below for the full list of affected codes.
  3. If you have health concerns or believe you are experiencing symptoms of an underactive thyroid, contact your healthcare provider or pharmacist immediately for guidance.
  4. Return any unused product to the place of purchase for a refund, throw it away, or contact IBSA Pharma Inc. directly for further instructions.
  5. Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) or visit www.fda.gov/safety/recalls for additional information.

Your Remedy Options

You have 2 options:

💰Option 1: Full Refund
How to: Contact your healthcare provider or pharmacist for guidance, or return any unused product to the place of purchase for a refund.
🗑️Option 2: Dispose of Product
How to: Throw the product away. For prescription medications, a DEA take-back location or pharmacy mail-back program is preferred when available.

Affected Products

Product: TIROSINT - SOL (levothyroxine sodium) Oral Solution (13 microgram/mL)
Variants: 13 microgram/mL, 6 pouches x 5 ampules
Lot Numbers:
220409 (Exp. 10/2023)
220956 (Exp. 03/2024)
NDC:
71858-0105-5

Rx Only; Manufactured for IBSA Pharma Inc. by IBSA Institut Biochimique SA.

Product: TIROSINT - SOL (levothyroxine sodium) Oral Solution (25 microgram/mL)
Variants: 25 microgram/mL, 6 pouches x 5 ampules
Lot Numbers:
220856 (Exp. 2/2024)
NDC:
71858-0110-5

Rx Only; Manufactured for IBSA Pharma Inc. by IBSA Institut Biochimique SA.

Product: TIROSINT - SOL (levothyroxine sodium) Oral Solution (37.5 microgram/mL)
Variants: 37.5 microgram/mL, 6 pouches x 5 ampules
Lot Numbers:
220552 (Exp. 11/2023)
221055 (Exp. 04/2024)
NDC:
71858-0112-5

Rx Only; Manufactured for IBSA Pharma Inc. by IBSA Institut Biochimique SA.

Product: TIROSINT - SOL (levothyroxine sodium) Oral Solution (44 microgram/mL)
Variants: 44 microgram/mL, 6 pouches x 5 ampules
Lot Numbers:
220553 (Exp. 11/2023)
221056 (Exp. 04/2024)
NDC:
71858-0113-5

Rx Only; Manufactured for IBSA Pharma Inc. by IBSA Institut Biochimique SA.

Product: TIROSINT - SOL (levothyroxine sodium) Oral Solution (50 microgram/mL)
Variants: 50 microgram/mL, 6 pouches x 5 ampules
Lot Numbers:
220407 (Exp. 10/2023)
220960 (Exp. 03/2024)
NDC:
71858-0115-5

Rx Only; Manufactured for IBSA Pharma Inc. by IBSA Institut Biochimique SA.

Product: TIROSINT - SOL (levothyroxine sodium) Oral Solution (62.5 microgram/mL)
Variants: 62.5 microgram/mL, 6 pouches x 5 ampules
Lot Numbers:
220556 (Exp. 11/2023)
221058 (Exp. 04/2024)
NDC:
71858-0117-5

Rx Only; Manufactured for IBSA Pharma Inc. by IBSA Institut Biochimique SA.

Product: TIROSINT - SOL (levothyroxine sodium) Oral Solution (75 microgram/mL)
Variants: 75 microgram/mL, 6 pouches x 5 ampules
Lot Numbers:
220853 (Exp. 02/2024)
NDC:
71858-0120-5

Rx Only; Manufactured for IBSA Pharma Inc. by IBSA Institut Biochimique SA.

Product: TIROSINT - SOL (levothyroxine sodium) Oral Solution (88 microgram/mL)
Variants: 88 microgram/mL, 6 pouches x 5 ampules
Lot Numbers:
220411 (Exp. 10/2023)
220854 (Exp. 02/2024)
NDC:
71858-0125-5

Rx Only; Manufactured for IBSA Pharma Inc. by IBSA Institut Biochimique SA.

Product: TIROSINT - SOL (levothyroxine sodium) Oral Solution (100 microgram/mL)
Variants: 100 microgram/mL, 6 pouches x 5 ampules
Lot Numbers:
220413 (Exp. 10/2023)
220964 (Exp. 3/2024)
NDC:
71858-0130-5

Rx Only; Manufactured for IBSA Pharma Inc. by IBSA Institut Biochimique SA.

Product: TIROSINT - SOL (levothyroxine sodium) Oral Solution (112 microgram/mL)
Variants: 112 microgram/mL, 6 pouches x 5 ampules
Lot Numbers:
220414 (Exp. 10/2023)
220852 (Exp. 02/2024)
220970 (Exp. 03/2024)
NDC:
71858-0135-5

Rx Only; Manufactured for IBSA Pharma Inc. by IBSA Institut Biochimique SA.

Product: TIROSINT - SOL (levothyroxine sodium) Oral Solution (125 microgram/mL)
Variants: 125 microgram/mL, 6 pouches x 5 ampules
Lot Numbers:
220855 (Exp. 2/2024)
NDC:
71858-0140-5

Rx Only; Manufactured for IBSA Pharma Inc. by IBSA Institut Biochimique SA.

Product: TIROSINT - SOL (levothyroxine sodium) Oral Solution (137 microgram/mL)
Variants: 137 microgram/mL, 6 pouches x 5 ampules
Lot Numbers:
220415 (Exp. 10/2023)
221052 (Exp. 04/2024)
NDC:
71858-0145-5

Rx Only; Manufactured for IBSA Pharma Inc. by IBSA Institut Biochimique SA.

Product: TIROSINT - SOL (levothyroxine sodium) Oral Solution (150 microgram/mL)
Variants: 150 microgram/mL, 6 pouches x 5 ampules
Lot Numbers:
220959 (Exp. 3/2024)
NDC:
71858-0150-5

Rx Only; Manufactured for IBSA Pharma Inc. by IBSA Institut Biochimique SA.

Product: TIROSINT - SOL (levothyroxine sodium) Oral Solution (175 microgram/mL)
Variants: 175 microgram/mL, 6 pouches x 5 ampules
Lot Numbers:
220416 (Exp. 10/2023)
221053 (Exp. 4/2024)
NDC:
71858-0155-5

Rx Only; Manufactured for IBSA Pharma Inc. by IBSA Institut Biochimique SA.

Product: TIROSINT - SOL (levothyroxine sodium) Oral Solution (200 microgram/mL)
Variants: 200 microgram/mL, 6 pouches x 5 ampules
Lot Numbers:
220418 (Exp. 10/2023)
220560 (Exp. 11/2023)
NDC:
71858-0160-5

Rx Only; Manufactured for IBSA Pharma Inc. by IBSA Institut Biochimique SA.

Product Images

1.	“TIROSINT-SOL 13 mcg/mL 30 units carton-box, NDC 71858-0105-5”

1. “TIROSINT-SOL 13 mcg/mL 30 units carton-box, NDC 71858-0105-5”

2.	“TIROSINT-SOL 25 mcg/mL 30 units carton-box, NDC 71858-0110-5”

2. “TIROSINT-SOL 25 mcg/mL 30 units carton-box, NDC 71858-0110-5”

3.	“TIROSINT-SOL 37.5 mcg/mL 30 units carton-box, NDC 71858-0112-5”

3. “TIROSINT-SOL 37.5 mcg/mL 30 units carton-box, NDC 71858-0112-5”

4.	“TIROSINT-SOL 44 mcg/mL 30 units carton-box, NDC 71858-0113-5”

4. “TIROSINT-SOL 44 mcg/mL 30 units carton-box, NDC 71858-0113-5”

5.	“TIROSINT-SOL 50 mcg/mL 30 units carton-box, NDC 71858-0115-5”

5. “TIROSINT-SOL 50 mcg/mL 30 units carton-box, NDC 71858-0115-5”

6.	“TIROSINT-SOL 62.5 mcg/mL 30 units carton-box, NDC 71858-0117-5”

6. “TIROSINT-SOL 62.5 mcg/mL 30 units carton-box, NDC 71858-0117-5”

7.	“TIROSINT-SOL 75 mcg/mL 30 units carton-box, NDC 71858-0120-5”

7. “TIROSINT-SOL 75 mcg/mL 30 units carton-box, NDC 71858-0120-5”

8.	“TIROSINT-SOL 88 mcg/mL 30 units carton-box, NDC 71858-0125-5”

8. “TIROSINT-SOL 88 mcg/mL 30 units carton-box, NDC 71858-0125-5”

9.	“TIROSINT-SOL 100 mcg/mL 30 units carton-box, NDC 71858-0130-5”

9. “TIROSINT-SOL 100 mcg/mL 30 units carton-box, NDC 71858-0130-5”

10.	“TIROSINT-SOL 112 mcg/mL 30 units carton-box, NDC 71858-0135-5”

10. “TIROSINT-SOL 112 mcg/mL 30 units carton-box, NDC 71858-0135-5”

11.	“TIROSINT-SOL 125 mcg/mL 30 units carton-box, NDC 71858-0140-5”

11. “TIROSINT-SOL 125 mcg/mL 30 units carton-box, NDC 71858-0140-5”

12.	“TIROSINT-SOL 137 mcg/mL 30 units carton-box, NDC 71858-0145-5”

12. “TIROSINT-SOL 137 mcg/mL 30 units carton-box, NDC 71858-0145-5”

13.	“TIROSINT-SOL 150 mcg/mL 30 units carton-box, NDC 71858-0150-5”

13. “TIROSINT-SOL 150 mcg/mL 30 units carton-box, NDC 71858-0150-5”

14.	“TIROSINT-SOL 175 mcg/mL 30 units carton-box, NDC 71858-0155-5”

14. “TIROSINT-SOL 175 mcg/mL 30 units carton-box, NDC 71858-0155-5”

15.	“TIROSINT-SOL 200 mcg/mL 30 units carton-box, NDC 71858-0160-5”

15. “TIROSINT-SOL 200 mcg/mL 30 units carton-box, NDC 71858-0160-5”

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 91556
Status: Resolved
Manufacturer: IBSA PHARMA INC
Sold By: pharmacies nationwide
Manufactured In: Switzerland, United States
Distributed To: Nationwide
Agency Last Updated: April 4, 2023

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · FDA Press Release · Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.